Including a range of outcome targets offers a broader view of fibromyalgia treatment outcome: Results from a retrospective review of multidisciplinary treatment

Musculoskeletal Care

Volumn 12, Issue 2, 2014, Pages 74-81

  Marcus, Dawn A ^a   Bernstein, Cheryl D ^a   Haq, Adeel ^a   Breuer, Paula ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Activities of daily living; Clinically meaningful; Pain drawing; Repetitions; Walking

Indexed keywords

ADULT; AGED; COGNITIVE THERAPY; FEMALE; FIBROMYALGIA; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; KINESIOTHERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; RETROSPECTIVE STUDY; SPINE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT EDUCATION AS TOPIC; RANGE OF MOTION, ARTICULAR; RETROSPECTIVE STUDIES; SPINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901845840     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.1056     Document Type: Article

References (26)

1. Al-Allaf AW (2007). Work disability and health system utilization in patients with fibromyalgia syndrome. Journal of Clinical Rheumatology 13: 199-201.
2. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB (2009). Minimal clinically important difference in the Fibromyalgia Impact Questionnaire. Journal of Rheumatology 36: 1304-11.
3. Bernstein CD, Albrecht KL, Marcus DA (2013). Milnacipran for fibromyalgia: A useful addition to the treatment armamentarium. Expert Opinion on Pharmacotherapy 14: 905-16.
4. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taibe C, Matucci-Cerinic M (2010). Prevalence of fibromyalgia: A survey of five European countries. Seminars in Arthritis and Rheumatism 39: 448-53.
5. Castel A, Fontova R, Mortull S, Periñán R, Poveda MJ, Miralles I, Cascón-Pereira R, Hernández P, Aragonés N, Salvat I, Castro S, Monterde S, Padrol A, Sala J, Añez C, Rull M (2013). Efficacy of a multidisciplinary fibromyalgia treatment adapted for women with low educational levels: A randomized controlled trial. Arthritis Care and Research 65: 421-31.
6. Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL (2004). Fibromyalgia: A randomised, controlled trial of a treatment programme based on self management. Annals of the Rheumatic Diseases 63: 290-6.
7. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y (2008). Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clinical Therapeutics 30: 1998-2004.
8. Einkauf DK, Gohdes ML, Jensen GM, Jewell MJ (1987). Changes in spinal mobility with increasing age in women. Physical Therapy 67: 370-5.
9. Farrar JY, Portenoy RK, Berlin JA, Kinman JL, Strom BL (2000). Defining the clinically important difference in pain outcome measures. Pain 88: 287-94.
10. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM (2001). Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-58.
11. Häuser W, Arnold B, Eich W, Felde E, Flügge C, Henningsen P, Hermann M, Köllner V, Kühn E, Nutzinger D, Offenbächer M, Schiltenwolf M, Sommer C, Thiene K, Kopp I (2008). Management of fibromyalgia syndrome - An interdisciplinary evidence-based guideline. German Medical Science 6: Doc 14.
12. Häuser W, Thieme K, Turk DC (2010a). Guidelines on the management of fibromyalgia syndrome - A systematic review. European Journal of Pain 14: 5-10.
13. Häuser W, Petzke F, Sommer C (2010b). Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. The Journal of Pain 11: 505-21.
14. Häuser W, Wolfe F, Tölle T, Uçeyler Y, Sommer C (2012). The role of antidepressants in the management of fibromyalgia syndrome: A systematic review and meta-analysis. CNS Drugs 26: 297-307.
15. Jones J, Rutledge DN, Jones KD, Matallana L, Rooks DS (2008). Self-assessed physical function levels of women with fibromyalgia: A national survey. Women's Health Issues 18: 406-12.
16. Kapandji IA (1974). The Physiology of the Joints. New York, NY: Longman Group Limited.
17. Lawrence RC, Fleson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GC, Jordan JM, Katz JN, Kremers HM, Wolfe F (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58: 26-35.
18. Marcus DA (2009). Fibromyalgia: Diagnosis and treatment options. Gender Medicine 6: 139-51.
19. McNally JD, Matheson DA, Bakowsky VS (2006). The epidemiology of self-reported fibromyalgia in Canada. Chronic Diseases in Canada 27: 9-16.
20. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, Bouter LM, de Vet HC (2008). Interpreting change scores for pain and functional status in low back pain: Towards international consensus regarding minimal important change. Spine 33: 90-4.
21. Saidu IA, Maduagwu SM, Abbas AD, Adetunji OO, Jajere AM (2011). Lumbar spinal mobility changes among adults with advancing age. Journal of Midlife health 2: 65-71.
22. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, Ferraz MB (2004). Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach. Journal of Rheumatology 31: 594-7.
23. Üeyler N, Häuser W, Sommer C (2008). A systematic review of the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis and Rheumatism 59: 1279-98.
24. Wennemer HK, Borg-Stein J, Gomba L, Delaney B, Rothmund A, Barlow D, Breeze G, Thompson A (2006). Functionally oriented rehabilitation program for patients with fibromyalgia. American Journal of Physical Medicine & Rehabilitation 85: 659-66.
25. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL (2008). Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss. Journal of Occupational and Environmental Medicine 50: 13-24.
26. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP, (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33: 160-72.